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Streptococcus mutans is the main pathogenic agent of dental caries. Glucosyltransferases (Gtfs) produced by
these bacteria are important virulence factors because they catalyze the extracellular synthesis of glucans that
are necessary for bacterial accumulation in the dental biofilm. The diversity of GtfB and GtfC isozymes was
analyzed in 44 genotypes of S. mutans that showed a range of abilities to form biofilms in vitro. Several
approaches were used to characterize these isozymes, including restriction fragment length polymorphism
analysis of the gtfB and gtfC genes, zymographic analysis of the identified GtfB and GtfC genotypes, and
quantitation of isozyme production in immunoblot experiments with specific monoclonal antibodies. A high
diversity of gtf genes, patterns of enzymatic activity, and isozyme production was identified among the isolates
tested. GtfC and, to a lesser extent, GtfB were produced in significantly higher amounts by strains that had
high biofilm-forming ability than by strains with low biofilm-forming ability. Biofilm formation was indepen-
dent of the GtfB and GtfC genotype. Atypical strains that showed an apparent single Gtf isozyme of interme-
diate size between GtfB and GtfC were also identified. The results indicate that various expression levels of
GtfB and GtfC isozymes are associated with the ability of distinct S. mutans genotypes to grow as biofilms,
strengthening the results of previous genetic and biochemical studies performed with laboratory strains. These
studies also emphasize the need to identify factors that control gtf gene expression.
Streptococcus mutans is the major pathogen of dental caries.
One of its most intensively studied virulence factors is the
ability to synthesize extracellular water-insoluble glucan from
sucrose through the activity of secreted glucosyltransferases
(Gtf), leading to bacterial accumulation in the dental biofilm.
Three distinct Gtfs (GtfB, GtfC, and GtfD) were demon-
strated to participate in the sucrose-dependent adherence pro-
cess (16, 23, 26). Antibodies raised against Gtfs have been
shown to protect against dental caries in animal models (18,
21). Gtfs have also been incorporated into vaccines used in
human clinical trials (3, 19, 20). GtfB and GtfC enzymes are
encoded by highly homologous genes that are organized in a
sequential operon-like fashion (17, 24). These two Gtfs are
involved in the synthesis of water-insoluble (1-3)-rich glucans
(17, 24). A third isotype, GtfD, shows less homology with GtfB
and GtfC and is encoded by a gene located elsewhere in the
chromosome. This enzyme catalyzes the synthesis of water-
soluble (1-6)-rich glucans (8).
Genes coding for each Gtf isozyme have been inactivated,
and the resulting mutant strains were analyzed for sucrose-
dependent adherence in vitro and cariogenicity in animal mod-
els. These studies indicated that GtfB and GtfC have the high-
est association with virulence (16, 26). We have shown that
there is significant variability in the ability to form biofilms in
vitro among a large group of clinical isolates containing distinct
S. mutans genotypes and have suggested that these variations
may be associated with differential expression of proteins in-
volved in the accumulation phase of biofilm growth (12).
A study of distinct genotypes that vary in biofilm growth may
help us to understand how virulence factor expression is re-
lated to the ability of S. mutans to accumulate in the dental
biofilm and ultimately help to explain the differences in caries
activity observed among S. mutans-infected children (11). To-
ward these goals, in this study, we characterized Gtf isozymes
with respect to gtf gene polymorphisms and enzyme production
and activity patterns in a large number of clinical isolates which
differ in their abilities to grow as biofilms. The results of our
study indicate that S. mutans biofilm formation is influenced
more by the amounts of GtfC and GtfB produced than by the
inherent gtf gene polymorphisms, suggesting that factors that
control expression of GtfB and GtfC may account for differ-
ences in virulence among infecting S. mutans strains.
MATERIALS AND METHODS
Bacterial strains and growth conditions. A total of 76 S. mutans isolates
included in this study were obtained from 35 young children (11) and included 44
distinct S. mutans amplitypes, as previously determined by AP-PCR (13). Lab-
oratory strains were S. mutans SJ32, UA130 (ATCC 700611), and GS5 (kindly
provided by H. K. Kuramitsu, State University of New York). S. mutans strains
were grown in either Todd-Hewitt broth (THB; Difco), brain heart infusion
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(Difco), or chemically defined medium (CDM) under anaerobic conditions (10%
H2, 10% CO2, 80% N2) or in candle jars.
DNA isolation. S. mutans chromosomal DNA was isolated by using a Master-
Pure DNA purification kit from Epicentre Technologies (Madison, Wis.) as
described by the manufacturer.
PCR-RFLP analysis of gtfB and gtfC. Polymorphisms of gtfB and gtfC genes
were identified by PCR-restriction fragment length polymorphism (RFLP) in the
44 S. mutans amplitypes and in strains SJ32, UA130, and GS5. Seven additional
isolates of duplicate amplitypes were also included to check agreement between
RFLP patterns of gtf genes and S. mutans AP-PCR identity, giving a total of 51
isolates tested. Since gtfB and gtfC sequences are sequentially arranged in the
chromosome and are highly homologous (76% amino acid sequence identity),
primer sets used for independent amplification of gtfB and gtfC included a
nonconserved region located between the GtfB and GtfC open reading frames.
The sequence used for primer design was obtained from S. mutans strain GS5
(GenBank accession number M17361). Figure 1 shows primer locations and
restriction maps of the gtfB and gtfC amplicons. Amplification of gtfB with the
specific primers GTFBF (5-CAAAGATGAAGAAGCAGTAAT-3) and
GTFBR (5-TTCTATAACAAAAGCACAATG-3) yielded amplicons of 5.2 kb.
Amplicons of 4.3 kb, corresponding to gtfC, were obtained with primers GTFCF
(5-TTGGAGGAAATATGGAAAAG-3) and GTFCR (5-GTCTAAAACGA
ACAGCACT-3). Amplification reactions were performed with a polymerase
enzyme system specific for the generation of long PCR products (Advantage2;
Clontech Labs, Inc.). The PCR included 23 cycles of denaturing at 95°C (30 s),
annealing at 59°C (1 min), and extension at 70°C (2 min). The restriction en-
zymes BsrI and SspI were selected for RFLP analysis of the gtfB and gtfC
amplicons, respectively, since restriction maps indicated that these enzymes give
the highest number of cleavage sites and yielded fragments suitable for electro-
phoretic separation. Fragments of digested gtfB and gtfC amplicons were sepa-
rated by electrophoresis at 5 V/cm for 3 h in 3 and 2% low-melting-point agarose
gels (GTG; Novagen), respectively, in 0.5 Tris-borate-EDTA. Gels were then
stained with ethidium bromide.
Measurement of GtfB, GtfC, and GtfD produced in culture fluids. After
overnight growth in CDM, bacterial suspensions were adjusted to the same
optical density (A550) so that the same size inocula were added to fresh CDM (4
ml) containing 10 M hydrochloride 4-(2-aminoethyl)-benzolsulfonylfluoride
(AEBSF) (Roche Diagnostics, Indianapolis, Ind.) (12). After growth for 18 h,
final absorbances of cultures (A550) were measured and cells were pelleted from
2 ml of culture. The supernatant was filtered through a 0.22-m-pore-size filter
membrane (Spin-X; Costar, New York, N.Y.) and immediately frozen at 70°C.
Fifty microliters of sample was diluted twofold in 0.02 M sodium phosphate
buffer (pH 6.8) and applied to nitrocellulose membranes (Bio-Rad, Foster City,
Calif.), as described elsewhere, by using a dot blot apparatus (Bio-Rad) (12).
Membranes were blocked overnight in 100 mM Tris-HCl, 2.5 mM NaCl (pH 7.5),
and 5% nonfat milk, followed by incubation with monoclonal antibodies (MAbs)
P72 (anti-GtfB), P32 (anti-GtfC), and P4 (anti-GtfD) (5) at dilutions of 1:60,
1:30, and 1:60, respectively, in the blocking buffer. Following 2 h of incubation at
room temperature with MAbs or the blocking buffer (negative control), mem-
branes were washed four times with 100 mM Tris buffer containing 0.25%
Tween, pH 7.5. Incubation with goat anti-mouse immunoglobulin G conjugated
with horseradish peroxidase (Amersham Biosciences, Piscataway, N.J.) was then
performed at room temperature for 2 h. Membranes were washed four times
with 100 mM Tris buffer containing 0.25% Tween and drained, and immunolog-
ical reactions were developed by using the ECL-plus system (Amersham). In-
tensities of dot blot reactions were quantified with ImageQuant software (Mo-
lecular Dynamics) from digital images of membranes exposed to X-ray films.
Samples of all strains were blotted to the same membrane for direct comparison,
and the immunoassay was repeated at least twice. The intensities of dot blots
were normalized according the final absorbance (A550) of the respective culture
to minimize the effect of varying growth rates. The A550 values ranged from 1.30
to 1.69 (mean  standard deviation [SD], 1.49  0.11).
Analysis of GtfB and GtfC activity patterns in zymographic assays. To com-
pare the patterns of GtfB and GtfC enzyme activity among the distinct RFLP
classes of gtfB and gtfC, 3 or more strains representative of each gtfB and gtfC
genotype identified were randomly selected from the 51 strains analyzed. These
strains represented a subset of 34 clinical isolates. Briefly, the samples of culture
fluids were obtained from 18-h cultures grown in 4 ml of brain heart infusion
during incubation in candle jars. These cultures had been inoculated with an
adjusted inoculum size of 18-h cultures from frozen stocks prepared under the
same conditions. The final absorbance (A550) of cultures used for enzyme anal-
ysis was measured again to check for variations in growth (mean  SD, 0.89 
0.10; range, 0.71 to 1.05). Bacterial cells were removed from 3 ml of culture by
centrifuging twice at 4°C (1,385  g, 3 min). Culture supernatants were dialyzed
at 4°C against 0.02 M sodium phosphate buffer, pH 6.8, containing 10 M
phenylmethylsulfonyl fluoride, followed by dialysis against 0.2 mM sodium phos-
phate containing 10 M phenylmethylsulfonyl fluoride, a protease inhibitor.
After dialysis, samples were concentrated 100-fold by lyophilization. To prepare
for electrophoresis, 7.5 l of each concentrated culture fluid was resuspended in
2 Laemmli buffer (1:1), boiled for 1 min, and applied to sodium dodecyl sulfate
(SDS)–6% polyacrylamide gels by using the mini-Protean II system (Bio-Rad).
GtfB and GtfC enzyme activities were analyzed in simultaneously run qua-
druplicate SDS–6% polyacrylamide gel electrophoresis (PAGE) gels. The first
gel was used for protein detection by staining with Coomassie blue. The second
gel was used for the zymogram assay. Proteins separated in the other two gels
were transferred to nitrocellulose membranes for detection of the corresponding
GtfB and GtfC isozymes in Western blot assays performed with MAbs P72
(anti-GtfB) and P32 (anti-GtfC), respectively.
For zymogram analysis, following electrophoretic separation, gels were washed
twice for 15 min each with renaturing buffer containing 2.5% Triton X-100. Gels
were then incubated for 18 h at 37°C with 0.2 M sodium phosphate buffer (pH
6.5) containing 0.2% dextran T70 and 5% sucrose. The reactions were stopped
by washing gels with distilled water at 4°C for 10 min, and digital images of the
resulting white opaque glucan bands, synthesized by Gtf within the gels, were
captured by using a black background to enhance visibility.
Western blot analyses of GtfB and GtfC from electrophoretic separation of
culture supernatants were performed as described above for the dot blot assay,
except that MAbs P72 and P32 were used at 1:200 dilutions. The antibody-
reactive GtfB and GtfC bands were detected by using the horseradish peroxi-
dase-conjugated goat anti-mouse immunoglobulin G reagent followed by the
ECL system (Amersham). The relationships of antibody-stained Gtf bands to the
corresponding glucan bands observed in zymograms were confirmed by measur-
ing the distances of antibody-recognized bands from prestained molecular size
markers (Gibco BRL, Carlsbad, Calif.), which were included in separate lanes of
FIG. 1. Chromosome locus of the GS5 strain containing the gtfB
and gtfC genes (GenBank accession number M17361). (A) Primer
pairs used for specific amplification of gtfB and gtfC genes are repre-
sented as black and shaded arrows, respectively. The restriction sites of
the 5.2-kb gtfB and 4.3-kb gtfC amplicons are represented by the
dashed lines; within them, the size of fragments are indicated. (B) PCR
products obtained with the GTFBF-GTFBR (lane 1) and GTFCF-
GTFCR (lane 2) primer pairs. In 18 isolates, efficient amplification of
the gtfC genes was not obtained. Instead, PCRs yielded two weaker
products as shown in lane 2b. Thus, RFLP analysis of gtfC could not be
performed with these 18 strains. ORF, open reading frame.
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all gels. Intensities of the zymographic and Western blot bands were obtained
from digital images captured by a scanning densitometer (Bio-Rad GS-700
imaging densitometer). To control for interassay variability, intensities of the
principal glucan and protein bands of all isolates tested were divided by the
intensity of a control strain (3VF2) used in all the experiments.
Biofilm formation in microtiter plates. Biofilm growth in microtiter plates was
initiated from 1:100 dilutions of 18-h THB cultures transferred into fresh me-
dium. THB contains trace amounts of sucrose, thus providing the substrate for
Gtf activities (7). Briefly, after incubation, planktonic cells were removed by
washing and the biofilms were stained with a 1% aqueous solution of crystal
violet. The absorbances of crystal violet dissolved from ethanol treatment of the
stained biofilms (A575) and of planktonic cultures grown under the same condi-
tions (A550) were measured.
Statistical analysis. Pearson correlation analyses were used to evaluate asso-
ciations between production of GtfB, GtfC, and GtfD (normalized according to
the A550 of the tested cultures) and biofilm or planktonic growth among S.
mutans amplitypes. Means of glucan band intensities were compared among the
PCR-RFLP patterns identified for their respective Gtf isozyme by the Kruskal-
Wallis U test.
RESULTS
Polymorphisms of gtfB and gtfC genes and zymographic
patterns. Significant genetic diversity was identified in both
gtfB and gtfC genes. Figure 2 illustrates the distinct represen-
tative classes of gtfB (Fig. 2A) and gtfC (Fig. 2B) genes iden-
tified in the RFLP analysis. The frequencies of each RFLP
class among the 44 S. mutans amplitypes tested are also shown
(Fig. 2). The gtfB RFLP class b was, as predicted, the pattern
identified in strain GS5. This same gtfB genotype was also
identified in strain SJ32 and in 8 clinical amplitypes (18.2%).
The gtfB RFLP class c was the most frequently detected geno-
type, observed in 40.9% of the clinical amplitypes (n  18) and
in UA130. Only strains 3SN1, 2SN3, and 4SM1 reflected gtfB
RFLP class f. PCR products corresponding to the 4.3-kb gtfC
gene were not efficiently generated in 18 strains, although GtfC
was recognized by the appropriate MAb (MAb P32) in the
immunological analysis. Thus, the gtfC RFLP patterns were
analyzed in 26 clinical amplitypes. Class k was the most fre-
quently identified gtfC genotype (n  12) and was also ob-
served in strain GS5. The gtfC RFLP class n genotype was
detected in strain SJ32 and 10 other distinct S. mutans
amplitypes.
Figure 3 shows representative protein, zymogram, and West-
ern blot patterns of Gtf isozyme activities identified in the 34
strains that demonstrated distinct gtfB and gtfC RFLP classes.
Strains 3SN1 and 4SM1 showed atypical patterns of Gtf activ-
ity, with an apparent single glucan-synthesized band of inter-
mediate size between the commonly detected GtfB (165.8
kDa) and GtfC (153 kDa) correspondent glucan bands. Three
other strains, 17A2, 2SN3, and 12JP3 (data not shown), also
showed this single band pattern. As in strain 3SN1 (Fig. 3),
strain 2SN3 did not produce detectable levels of GtfB in the
immunological assays (see below). Similar to 4SM1 (Fig. 3),
other strains (17A2 and 12JP3) showed detectable levels of
GtfB, although the anti-GtfB MAb P72 reactions in Western
blot analysis of these strains were with a protein that migrated
more rapidly than typically seen for GtfB.
Strains that did not demonstrate GtfB reactivity by Western
blot analyses (e.g., 5ST1, 11SSST2, and 3SN1) (Fig. 3) did not
contain cell-associated protein, as observed in Western blot
assays with cell extracts (data not shown). There was general
agreement between gtf polymorphisms and Gtf production pat-
terns when strains representing the same amplitype (AP-PCR
profile) were compared, indicating that the genetic and phe-
notypic traits of the Gtf expressed were related to the genetic
background of the isolates tested. Intensities of Gtf-related
glucan bands, adjusted by the A550 of the applied cultures
ranged from 0.44 to 2.30 for GtfB (mean  SD, 1.09  0.49)
and from 0.71 to 9.64 for GtfC (mean  SD, 2.00  1.83). No
significant differences in activity were detected when glucan
band intensities were compared among distinct gtfB (Kruskal-
Wallis, P  0.651) and gtfC (Kruskal-Wallis, P  0.091) RFLP
classes.
Comparisons of Gtf production and gtf gene polymorphisms
with biofilm growth. Relative amounts of secreted Gtf
isozymes quantified by immuno dot blot analysis were quite
variable among the 44 S. mutans amplitypes tested. Relative
FIG. 2. (A) Ten distinct RFLP classes of the gtfB amplicon (a to j)
were detected by BsrI digestion among the clinical strains analyzed.
(B) Patterns of RFLP identified by SspI digestion of gtfC amplicons (k
to o).
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amounts of GtfB, expressed as the intensities of dot blot reac-
tivities, normalized by the A550 of the cultures tested, ranged
from 0 to 131 arbitrary units (U) (mean  SD, 54.8  44.1 U).
Relative amounts of GtfC ranged from 19.2 to 80.7 U for GtfC
(mean  SD, 50.2  16.8 U). For GtfD, relative amounts
ranged from 4.5 to 72.7 U (mean  SD, 20.7  15.2 U).
Relative amounts of GtfB produced were associated with
amounts of GtfC in a high proportion of amplitypes studied
(Pearson correlation, r  0.49, P 	 0.001) but not with
amounts of GtfD (r  0.01; P  0.95). Amounts of GtfC also
were not associated with amounts of GtfD (r  0.07; P  0.62).
To investigate the influence of varying production of Gtf
isozymes from clinical isolates on their ability to grow as bio-
films, the relative amounts of GtfB, GtfC, and GtfD produced
were compared to biofilm growth measurements (Fig. 4). Rel-
ative amounts of GtfC produced by the 44 amplitypes were
significantly associated with the ability of these strains to grow
as biofilms (Pearson correlation, r  0.36, P 	 0.02). Amounts
of GtfB expressed were also associated with biofilm formation,
although to a lower extent than those of GtfC (Pearson cor-
relation, r  0.31, P 	 0.05). An inverse relationship was
observed between amounts of GtfD produced and biofilm
growth (Pearson correlation, r  0.33, P 	 0.05). Planktonic
growth was not related to levels of Gtf isozyme production
(GtfB, r  0.39, P  0.01; GtfC, r  0.48, P  0.76; GtfD,
r  0.20, P  0.20).
Comparisons of gtf polymorphisms with biofilm growth
showed no clear differences in means of biofilm intensities
between amplitypes carrying distinct gtfB and gtfC genotypes.
The five S. mutans amplitypes expressing an apparent single
Gtf synthesizing glucan band of intermediate size between
GtfB and GtfC showed low biofilm formation, with crystal
violet intensities (A575) ranging from 0.16 to 0.35 (mean, 0.26;
SD, 0.07).
DISCUSSION
The production and activity of S. mutans Gtfs and their
association with virulence has been studied extensively in lab-
oratory strains (16, 18, 23, 26). Mutants of gtfB, gtfC, or gtfD
from strain UA130 showed a significantly lower potential to
induce caries on smooth tooth surfaces in animal models when
compared to the wild type, suggesting that all Gtf isozymes are
important for colonization and caries induction (26). However,
analyses of GS5 mutants carrying different combinations of gtf
gene deletions indicated that GtfB and GtfC were important in
sucrose-dependent adhesion in vitro while deletion of GtfD
had only a modest effect (23). The gtfC mutations in GS5
caused the largest decrease in adherence in vitro (23). Since
these studies suggested that differential expression of gtf genes
may be related to phenotypic expressions of virulence, we
explored the potential variability in the expression and activity
of Gtf isotypes in a large group of clinical S. mutans isolates
that had successfully colonized young children but differed in
in vitro biofilm growth.
Previously, we compared both sucrose-dependent adherence
on glass surfaces and Gtf activities among clinical strains iso-
lated from young children who exhibited large differences in
caries activity and established that children with high caries
activity were often infected by strains showing significantly
FIG. 3. Representative patterns of Gtf isozyme production and activities analyzed in clinical isolates representative of the gtfB and gtfC
genotypes identified by RFLP. GtfB and GtfC were electrophoretically separated on quadruplicate SDS–6% PAGE gels and then analyzed for
protein by Coomassie staining, for glucan production after incubation of gels with sucrose, and immunologically for GtfB and GtfC in Western
blots developed with MAb P72 or MAb P32, respectively. Strains are indicated above each lane. RFLP classes of gtfB and gtfC amplicons are shown
beneath each lane. Note that strains 4SM1 and 3SN1 presented a glucan-synthesized band of intermediate size between the typical GtfB- and
GtfC-related glucan bands. Strains 5ST1 and 11SSST2, representative of a single S. mutans amplitype, did not display detectable levels of GtfB.
VOL. 42, 2004 Gtf ISOZYME DIVERSITY IN S. MUTANS ISOLATES 4589
higher amounts of glucan synthesis compared to strains infect-
ing caries-free children (14). The results suggested that diver-
sity in Gtf expression or specific activity may be associated with
the level of cariogenicity. However, analyses of specific Gtf
isozymes were not performed (14).
The expression patterns of GtfB, GtfC, and GtfD were char-
acterizedy using isozyme-specific MAbs (5, 22). This is the first
study that characterized Gtf isozymes in a large number of
clinical isolates, and the results support the notion that differ-
ences in expression of GtfB and GtfC are associated with the
ability of the organism to form biofilms. The relationships
between amounts of each Gtf isotype secreted with amounts of
biofilm is consistent with the phenotypic traits observed in gtfB,
gtfC, and gtfD mutants, supporting a pronounced role for GtfC
in adherence (23). Contrary results have been observed with
respect to the individual participation of GtfD in the virulence
phenotype (23, 26). We found the amplitypes with the highest
biofilm growth showed the lowest amounts of GtfD produc-
tion, which may explain the lack of association observed be-
tween amounts of total secreted Gtfs and biofilm growth pre-
viously reported (12).
In the present study, no relationship was detected between
specific gtfC genotypes and amounts of GtfC produced, which
concurred with the assumption that differences in GtfC
amounts were indeed due to variation in expression levels
rather than to gtfC polymorphisms. Five atypical strains (3SN1,
2SN3, 4SM1, 17A2, and 12JP3) showed a GtfB/C intermediate
size glucan band and a low level of biofilm growth (A575 from
0.16 to 0.35). The Western blot patterns of these strains were
similar to those previously observed with the strain UA101
(27). The intermediate size Gtf of UA101 had been suggested
to be a product of homologous recombination of gtfB with gtfC
in the UA101 ancestor (27).
Although an important role for GtfB and GtfC in the viru-
lence of S. mutans was defined, the mechanisms that control
expression of these proteins are poorly understood. For most
genotypes analyzed in this study, the amounts of GtfB were
positively associated with the amounts of GtfC expressed
(Pearson correlation, r  0.49, P 	 0.001), supporting the
notion that gtfB and gtfC genes are part of an operon (29).
However, several high GtfC producers showed no detectable
GtfB (3SN1, 2SN3, 5ST1, and 11SSST1), a finding which is
consistent with independent transcription of these genes, as
proposed in other studies (6). Isolates 5ST1 and 11SSST3
showed no detectable levels of GtfB in immunological assays,
although a glucan band of migration similar to that synthesized
by the GtfB isozyme was detected (Fig. 3). These apparently
GtfB-related glucan bands could, however, be the consequence
of GtfD activities because this latter isozyme has a molecular
mass of approximately 160 kDa and may not have adequately
separated from GtfB on the SDS–6% PAGE gels (Fig. 2).
Another possible explanation for GtfB-like glucan bands in
strains with no detectable GtfB in Western blots is that the
GtfB isozymes produced by these strains were not recognized
by the MAb P72, although their gtfB genes were of RFLP class
c, the same as identified in high GtfB producers (Fig. 3).
Sequence analysis of the whole gtf locus in these atypical S.
mutans amplitypes may help to resolve these anomalies.
Measurement of glucan band intensities should be an indi-
rect measurement of Gtf expression. However, zymograph
variations were not always related to Western blot intensities
(Fig. 3). The similar sizes of the Gtf isotypes made it difficult to
determine the precise location of glucan-related bands, even
when parallel Western blot assays were probed with specific
MAbs. Despite this limitation, the relative amounts of glucans
synthesized, which corresponded to the migration position of
either GtfB and GtfC, were positively associated with biofilm
FIG. 4. Distribution of Gtf isozyme production and biofilm growth
in 44 S. mutans amplitypes. The relative amounts of Gtf produced were
expressed as the intensities of the immunological dot blot reactions
adjusted for the A550 of the cultures tested. Biofilm growth was ex-
pressed as the A575 of ethanol-eluted crystal violet of the stained
biofilms. A significant positive association was observed between
amounts of GtfB (A) and GtfC (B) produced and biofilm formation.
No positive association was detected between amounts of GtfD and
biofilm growth (C).
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growth in a subset of 29 strains (data not shown). The five
atypical strains that synthesized single glucan bands were not
included in these analyses. Variations in migration patterns,
enzymatic kinetics, or protein degradation could influence zy-
mographic results. For example, we cannot exclude the possi-
bility that some glucan bands, which were associated with GtfC
because of their migration position, could result from de-
graded GtfB that retained activity but migrated faster.
Given the high number of polymorphisms identified in the
gtf genes, we presumed that different Gtfs may vary in their
enzymatic kinetics, although no specific gtf genotypes were
related to low or high enzymatic activity measured in zymo-
grams. Polymorphisms in gtf genes have been described
among isolates from other populations (1, 2, 4), including
several that encode silent mutations that have no effect on
isozyme activity (2). The gtfB RFLP class c was the most
common genotype, followed by class b, which included the
laboratory GS5 strain. The majority of clinical isolates also
demonstrated gtfC of pattern k, the same as identified in
GS5. Previous sequence comparison of the gtfB and gtfC
genes between five clinical isolates and the GS5 laboratory
strain have indicated several frameshift mutations in the
gtfB and gtfC genes in GS5 which accounted for changes in
the protein sequence (4). Besides the five atypical strains
observed in the present study, no other clear influence of gtf
gene polymorphism on isozyme production, activity pattern,
or biofilm growth were observed. Thus, the results indicate
that the amount of Gtf isozyme produced is more important
to biofilm growth than gtf gene polymorphism. The positive
associations of GtfB/C production with biofilm formation in
vitro, determined from the large number of clinical isolates
tested, suggests that further studies are required to eluci-
date mechanisms that regulate the expression of these
isozymes. It is noteworthy that other factors could contrib-
ute to the variability in the amounts of Gtfs produced. For
example, strains could differ in the affinities of their ex-
pressed Gtfs for the cell surface. We have only quantified
Gtfs in culture fluids, since it has been shown that essentially
all Gtf is released into the supernatant when strains are
grown in non-sucrose-containing medium (7). Also, differ-
ences in the turnover of extracellular proteins cannot be
excluded.
Experiments with strains GS5 and UA130 with reporter
genes fused to the promoter sequences of gtfB/C indicated that
the expression of these gtf genes is enhanced in bacteria grow-
ing as biofilms compared to planktonic growth (9, 25, 29). The
amounts of Gtf that we quantified were from culture superna-
tants of planktonic cultures, and its relationship with biofilm
growth suggests an intrinsic diversity in expression. Chloram-
phenicol acetyltransferase gene fusions performed with two S.
mutans variant strains that diverged in the production of sev-
eral proteins involved in virulence indicated that differences in
the production of GtfC and GtfB were due to transcriptional
activities of their respective gtf genes. Since no relationships to
gtfB/C promoter region polymorphisms were identified, other
factors controlling multiple virulence gene expression were
suggested (28). In the present study, sequencing of promoter
regions of the strains with divergent expression of GtfB and
GtfC may shed new light on this question. A peak of expression
of gtfB and gtfC genes was observed at the beginning of the log
phase in planktonic cultures, suggesting that a cell density-
dependent intercell communication system may play a role in
regulating expression of gtfB/C genes (6). Since the biofilm
growth phenotype was also shown to be regulated by such cell
density-dependent systems (10, 15), factors important for bio-
film growth which affect the expression of gtf genes were hy-
pothesized (9). Alternatively, independent factors controlling
gtf expression may increase the ability of distinct genotypes to
grow and accumulate in the biofilm phase. Comparative tran-
scriptional profiling or differential display analysis between the
clinical strains described herein which exhibit highly divergent
patterns of Gtf isozyme production may reveal factors involved
in the regulation of gtf genes.
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